NCT02186483

Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin

An Open-label, Randomized, Multiple-dose, Crossover Study to Evaluate the Drug-drug Interaction Following Coadministration of Metformin and Rosuvastatin in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the pharmacokinetic drug interaction between Metformin and Rosuvastatin in healthy male volunteers.

Detailed description

Drug-drug Interaction Following Co-administration of Metformin and Rosuvastatin in Healthy Male Volunteers

Conditions

• Hyperlipidemia
• Diabetes

Interventions

Type	Name	Description
DRUG	Metformin	Metformin,1000mg, once daily
DRUG	Rosuvastatin	Rosuvastatin, 20 mg, once daily
DRUG	Metformin and Rosuvastatin	Metformin, 1000mg, once daily Rosuvastatin, 20mg, once daily

Timeline

• Start date: 2014-08-01
• Primary completion: 2015-02-01
• Completion: 2015-02-01
• First posted: 2014-07-10
• Last updated: 2018-03-29

Locations

1 site across 1 country: South Korea